Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis
Status:
Completed
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
This clinical trial is designed to study the effectiveness and safety of mifepristone in the
treatment of symptomatic adenomyosis with multi center, random, double blind and controlled
clinical trials. This multicenter study is performed in 150 subjects who are diagnosed as
adenomyosis . Twelve weeks of randomization, allocation concealment, double-blind,
placebo-controlled, parallel grouping. Subjects are randomly assigned to one of two treatment
groups and received one of the following treatments:
1. Mifepristone tablets of 10mg, 1 tablet daily, oral
2. Placebo, 1 tablet daily, oral
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
xinmei zhang
Collaborators:
Anhui Province Cancer Hospital First Affiliated Hospital of Wenzhou Medical University Huzhou Maternity and Child Care Hospital Jiaxing Maternity and Child Health Care Hospital Jinhua Municipal Central Hospital Ningbo Maternity and Child Care Hospital Second Affiliated Hospital, School of Medicine, Zhejiang University Shaoxing People's Hospital Shaoxing Women and Children's Hospital Sir Run Run Shaw Hospital Taizhou First People's Hospital The Affiliated Hospital of Medical School of Ningbo University The Central Hospital of Lishui City The People's Hospital of Quzhou The People's Hospital of Quzhou City Zhoushan Maternity and Infant Hospital